Published in Arthritis Res Ther on March 31, 2005
Hyaluronan as an immune regulator in human diseases. Physiol Rev (2011) 2.74
Joint pain. Exp Brain Res (2009) 1.29
Biomechanical signals suppress proinflammatory responses in cartilage: early events in experimental antigen-induced arthritis. J Immunol (2006) 1.04
Anti-inflammatory effects of hyaluronan in arthritis therapy: Not just for viscosity. Int J Gen Med (2009) 1.00
Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan-induced knee joint synovitis in the rat. Br J Pharmacol (2010) 0.96
Hyaluronan modulates accumulation of hypoxia-inducible factor-1 alpha, inducible nitric oxide synthase, and matrix metalloproteinase-3 in the synovium of rat adjuvant-induced arthritis model. Arthritis Res Ther (2011) 0.93
AMPA/kainate glutamate receptors contribute to inflammation, degeneration and pain related behaviour in inflammatory stages of arthritis. Ann Rheum Dis (2013) 0.85
Strategies for controlled delivery of biologics for cartilage repair. Adv Drug Deliv Rev (2014) 0.85
Aspects of the biology of hyaluronan, a largely neglected but extremely versatile molecule. Wien Med Wochenschr (2006) 0.85
Effects of hyaluronan treatment on lipopolysaccharide-challenged fibroblast-like synovial cells. Arthritis Res Ther (2007) 0.84
Extracellular matrix-blood composite injection reduces post-traumatic osteoarthritis after anterior cruciate ligament injury in the rat. J Orthop Res (2015) 0.80
Intra-articular injection of hyaluronate and indomethacin in rabbits with antigen-induced arthritis. Rheumatol Int (2007) 0.79
Efficacy of an immunotoxin to folate receptor beta in the intra-articular treatment of antigen-induced arthritis. Arthritis Res Ther (2012) 0.79
Videoradiographic analysis of the range of motion in unilateral experimental knee joint arthritis in rats. Arthritis Res Ther (2011) 0.79
Preventing effects of joint contracture by high molecular weight hyaluronan injections in a rat immobilized knee model. Int J Clin Exp Pathol (2015) 0.76
Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem (1998) 4.86
Bilateral symmetric inflammatory reaction to hylan G-F 20 injection. Arthritis Rheum (2001) 3.55
Macrophages in rheumatoid arthritis. Arthritis Res (2000) 3.40
Chemical basis for the histological use of safranin O in the study of articular cartilage. J Bone Joint Surg Am (1971) 3.37
Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J Rheumatol (1995) 2.37
Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis (1985) 2.14
Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis (1993) 1.98
The structure and function of hyaluronan: An overview. Immunol Cell Biol (1996) 1.84
Viscosupplementation: therapeutic mechanisms and clinical potential in osteoarthritis of the knee. J Am Acad Orthop Surg (2000) 1.68
Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology (1980) 1.67
Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J Clin Invest (1980) 1.56
Toward imaging biomarkers for osteoarthritis. Clin Orthop Relat Res (2004) 1.51
Microspectrophotometric quantitation of glycosaminoglycans in articular cartilage sections stained with Safranin O. Histochemistry (1985) 1.42
Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. Arthritis Rheum (1986) 1.30
Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats. Arthritis Res Ther (2003) 1.29
Prediction of permanent work disability in a follow-up study of early rheumatoid arthritis: results of a tree structured analysis using RECPAM. Br J Rheumatol (1996) 1.24
Hyaluronate inhibition of cell proliferation. Arthritis Rheum (1987) 1.14
Systemic macrophage activation in locally-induced experimental arthritis. J Autoimmun (2001) 1.13
Antioxidant activity of synovial fluid, hyaluronic acid, and two subcomponents of hyaluronic acid. Synovial fluid scavenging effect is enhanced in rheumatoid arthritis patients. Arthritis Rheum (1988) 1.11
Oxygen radicals, inflammation, and arthritis: pathophysiological considerations and implications for treatment. Semin Arthritis Rheum (1991) 1.10
Intra-articular injection of hyaluronate (SI-6601D) improves joint pain and synovial fluid prostaglandin E2 levels in rheumatoid arthritis: a multicenter clinical trial. Clin Exp Rheumatol (2001) 1.09
Effect of hylan on cartilage and chondrocyte cultures. J Orthop Res (1992) 1.07
Long-distance running causes site-dependent decrease of cartilage glycosaminoglycan content in the knee joints of beagle dogs. Arthritis Rheum (1993) 1.04
Effects of hyaluronic acid on the release of proteoglycan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines. Arthritis Rheum (1993) 1.00
Hyaluronan-mediated protective effect against cell damage caused by enzymatically produced hydroxyl (OH.) radicals is dependent on hyaluronan molecular mass. Cell Biochem Funct (1994) 0.99
Therapeutic effect of intra-articular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee. Int J Clin Pharmacol Ther Toxicol (1982) 0.93
Concentrations of glycosaminoglycans in synovial fluids and their relation with immunological and inflammatory mediators in rheumatoid arthritis. Ann Rheum Dis (1990) 0.93
Induction of flare-up reactions in rat antigen-induced arthritis. J Autoimmun (1995) 0.93
Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: I. In vitro. Osteoarthritis Cartilage (1997) 0.90
Proteoglycan concentration in synovial fluid: predictor of future cartilage destruction in rheumatoid arthritis? Br Med J (Clin Res Ed) (1987) 0.90
Influence of cyclosporin A on cytokine levels in synovial fluid and serum of rats with antigen-induced arthritis. Agents Actions (1994) 0.87
Inhibition of interleukin 1-mediated proteoglycan degradation in bovine articular cartilage explants by addition of sodium hyaluronate. Am J Vet Res (1992) 0.86
Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: II. In vivo. Osteoarthritis Cartilage (1997) 0.86
Intra-articular injection of high molecular weight hyaluronan after arthrocentesis as treatment for rheumatoid knees with joint effusion. Rheumatol Int (2002) 0.85
Antioxidant effects of hyaluronan and its alpha-methyl-prednisolone derivative in chondrocyte and cartilage cultures. Semin Arthritis Rheum (1996) 0.84
Different immunological mechanisms contribute to cartilage destruction in antigen-induced arthritis. Exp Toxicol Pathol (1994) 0.84
Periarticular bone alterations in chronic antigen-induced arthritis: free and liposome-encapsulated clodronate prevent loss of bone mass in the secondary spongiosa. Clin Immunol (1999) 0.83
Inhibitory effects of hyaluronan on neutrophil-mediated cartilage degradation. Connect Tissue Res (1993) 0.83
123I-antileukoproteinase scintigraphy reveals microscopic cartilage alterations in the contralateral knee joint of rats with "monarticular" antigen-induced arthritis. Arthritis Rheum (2000) 0.82
Modulation of mitogen-dependent lymphocyte stimulation by hyaluronic acid. J Rheumatol (1984) 0.82
Adverse reaction to Hylan GF-20. J Rheumatol (2000) 0.81
Aromatic trap analysis of free radicals production in experimental collagen-induced arthritis in the rat: protective effect of glycosaminoglycans treatment. Free Radic Res (2003) 0.78
In vitro effects of hyaluronan on prostaglandin E2 induction by interleukin-1 in rabbit articular chondrocytes. Agents Actions (1993) 0.76
Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med (2004) 5.08
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol (2005) 4.68
Perspective: Evolution and detection of genetic robustness. Evolution (2003) 4.10
Robustness can evolve gradually in complex regulatory gene networks with varying topology. PLoS Comput Biol (2007) 3.09
Cryptic genetic variation promotes rapid evolutionary adaptation in an RNA enzyme. Nature (2011) 2.63
TGF-beta and fibrosis in different organs - molecular pathway imprints. Biochim Biophys Acta (2009) 2.44
Asymmetric sequence divergence of duplicate genes. Genome Res (2003) 2.28
Neutralism and selectionism: a network-based reconciliation. Nat Rev Genet (2008) 2.15
Structure and evolution of protein interaction networks: a statistical model for link dynamics and gene duplications. BMC Evol Biol (2004) 2.01
Duplicate genes and robustness to transient gene knock-downs in Caenorhabditis elegans. Proc Biol Sci (2004) 1.94
Convergent evolution of gene circuits. Nat Genet (2003) 1.89
Influence of metabolic network structure and function on enzyme evolution. Genome Biol (2006) 1.79
The robustness and evolvability of transcription factor binding sites. Science (2014) 1.76
Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160-1172). Int J Radiat Oncol Biol Phys (2005) 1.75
Thermal ablation of tumors using magnetic nanoparticles: an in vivo feasibility study. Invest Radiol (2002) 1.61
In vivo molecular imaging of experimental joint inflammation by combined (18)F-FDG positron emission tomography and computed tomography. Arthritis Res Ther (2010) 1.60
Growth temperature and genome size in bacteria are negatively correlated, suggesting genomic streamlining during thermal adaptation. Genome Biol Evol (2013) 1.59
Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J Immunol (2007) 1.58
Molecular evolution in large genetic networks: does connectivity equal constraint? J Mol Evol (2004) 1.55
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol (2012) 1.54
Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target. Arthritis Rheum (2008) 1.53
Interventional therapy of bifurcation lesions: a TIMI flow-guided concept to treat side branches in bifurcation lesions--a prospective randomized clinical study (Thueringer bifurcation study, THUEBIS study as pilot trial). Circ Cardiovasc Interv (2009) 1.52
Severe accidental hypothermia with or without hemodynamic instability: rewarming without the use of extracorporeal circulation. Wien Klin Wochenschr (2002) 1.52
Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology (2002) 1.44
Evolutionary plasticity and innovations in complex metabolic reaction networks. PLoS Comput Biol (2009) 1.43
Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice. Arthritis Res Ther (2011) 1.42
Export aspiration system in patients with acute coronary syndrome and visible thrombus provides no substantial benefit. Catheter Cardiovasc Interv (2007) 1.39
A latent capacity for evolutionary innovation through exaptation in metabolic systems. Nature (2013) 1.38
The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res Ther (2005) 1.34
A model of protein translation including codon bias, nonsense errors, and ribosome recycling. J Theor Biol (2005) 1.32
Effects of a computer-based nursing documentation system on the quality of nursing documentation. J Med Syst (2007) 1.31
Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study--trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01). J Clin Oncol (2003) 1.30
Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther (2007) 1.29
Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads. Osteoarthritis Cartilage (2004) 1.28
A statistical framework for combining and interpreting proteomic datasets. Bioinformatics (2004) 1.28
The cytokine TNFalpha increases the proportion of DRG neurones expressing the TRPV1 receptor via the TNFR1 receptor and ERK activation. Mol Cell Neurosci (2007) 1.27
Reproducibility of allergen, endotoxin and fungi measurements in the indoor environment. J Expo Anal Environ Epidemiol (2003) 1.27
Specialization can drive the evolution of modularity. PLoS Comput Biol (2010) 1.27
Efficient characterization of high-dimensional parameter spaces for systems biology. BMC Syst Biol (2011) 1.26
GenomeHistory: a software tool and its application to fully sequenced genomes. Nucleic Acids Res (2002) 1.25
Influence of prebiotics and antioxidants in bread on the immune system, antioxidative status and antioxidative capacity in male smokers and non-smokers. Br J Nutr (2007) 1.24
CXCR5- and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis. Arthritis Rheum (2007) 1.23
Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin. J Clin Oncol (2011) 1.20
Relative percentage and zonal distribution of mesenchymal progenitor cells in human osteoarthritic and normal cartilage. Arthritis Res Ther (2011) 1.19
New structural variation in evolutionary searches of RNA neutral networks. Biosystems (2006) 1.17
Protein robustness promotes evolutionary innovations on large evolutionary time-scales. Proc Biol Sci (2008) 1.16
X-ray detection of structural orientation in human articular cartilage. Osteoarthritis Cartilage (2004) 1.15
High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells. BMC Biotechnol (2013) 1.13
Genotype networks in metabolic reaction spaces. BMC Syst Biol (2010) 1.12
Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients. Eur J Radiol (2005) 1.11
Phenotypic plasticity can facilitate adaptive evolution in gene regulatory circuits. BMC Evol Biol (2011) 1.09
Evolution of viral proteins originated de novo by overprinting. Mol Biol Evol (2012) 1.09
A comparison of genotype-phenotype maps for RNA and proteins. Biophys J (2012) 1.09
The Systems Biology Research Tool: evolvable open-source software. BMC Syst Biol (2008) 1.08
Effect of chemoradiotherapy with gemcitabine and cisplatin on locoregional control in patients with primary inoperable pancreatic cancer. World J Surg (2004) 1.08
Batch and continuous culture-based selection strategies for acetic acid tolerance in xylose-fermenting Saccharomyces cerevisiae. FEMS Yeast Res (2011) 1.07
Cooperation of Ras- and c-Myc-dependent pathways in regulating the growth and invasiveness of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheum (2004) 1.07
Risk of advanced colorectal neoplasia according to age and gender. PLoS One (2011) 1.05
Evolutionary innovations and the organization of protein functions in genotype space. PLoS One (2010) 1.05
Neutral network sizes of biological RNA molecules can be computed and are not atypically small. BMC Bioinformatics (2008) 1.05
'Glocal' robustness analysis and model discrimination for circadian oscillators. PLoS Comput Biol (2009) 1.05
Superessential reactions in metabolic networks. Proc Natl Acad Sci U S A (2012) 1.02
In vivo imaging of experimental arthritis with near-infrared fluorescence. Arthritis Rheum (2004) 1.02
Cytokine mRNA and protein expression in primary-culture and repeated-passage synovial fibroblasts from patients with rheumatoid arthritis. Arthritis Res (2001) 1.01
Hsp90 is important for fecundity, longevity, and buffering of cryptic deleterious variation in wild fly populations. BMC Evol Biol (2012) 1.01
Automatic generation of predictive dynamic models reveals nuclear phosphorylation as the key Msn2 control mechanism. Sci Signal (2013) 1.00
Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer. JOP (2006) 1.00
Identification of intra-group, inter-individual, and gene-specific variances in mRNA expression profiles in the rheumatoid arthritis synovial membrane. Arthritis Res Ther (2008) 1.00
Direct time-of-flight for quantitative, real-time in-beam PET: a concept and feasibility study. Phys Med Biol (2007) 0.99
Trimeric membrane-anchored gp41 inhibits HIV membrane fusion. J Biol Chem (2004) 0.99
Differential effects of locally and systemically administered soluble glycoprotein 130 on pain and inflammation in experimental arthritis. Arthritis Res Ther (2010) 0.99
Gait abnormalities differentially indicate pain or structural joint damage in monoarticular antigen-induced arthritis. Pain (2009) 0.99
Range assessment in particle therapy based on prompt γ-ray timing measurements. Phys Med Biol (2014) 0.99
Human knee and ankle cartilage explants: catabolic differences. J Orthop Res (2002) 0.99
Pervasive indels and their evolutionary dynamics after the fish-specific genome duplication. Mol Biol Evol (2012) 0.98
Hypoxic conditions during expansion culture prime human mesenchymal stromal precursor cells for chondrogenic differentiation in three-dimensional cultures. Cell Transplant (2011) 0.98
Protein material costs: single atoms can make an evolutionary difference. Trends Genet (2008) 0.98
Effects of recombination on complex regulatory circuits. Genetics (2009) 0.97
Developmental changes in cerebral autoregulatory capacity in the fetal sheep parietal cortex. J Physiol (2002) 0.97
Prevention of bone loss during 56 days of strict bed rest by side-alternating resistive vibration exercise. Bone (2009) 0.96
Nonlinear properties of vagal and sympathetic modulations of heart rate variability in ovine fetus near term. Am J Physiol Regul Integr Comp Physiol (2008) 0.96
Molecular evolution in the yeast transcriptional regulation network. J Exp Zool B Mol Dev Evol (2004) 0.96
Stimulation of collagenase 3 expression in synovial fibroblasts of patients with rheumatoid arthritis by contact with a three-dimensional collagen matrix or with normal cartilage when coimplanted in NOD/SCID mice. Arthritis Rheum (2002) 0.96
Exhaustive identification of steady state cycles in large stoichiometric networks. BMC Syst Biol (2008) 0.96
The anti-inflammatory effects of sympathectomy in murine antigen-induced arthritis are associated with a reduction of Th1 and Th17 responses. Ann Rheum Dis (2011) 0.95
Batch correction of microarray data substantially improves the identification of genes differentially expressed in rheumatoid arthritis and osteoarthritis. BMC Med Genomics (2012) 0.95
Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. Radiother Oncol (2006) 0.95
Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells. Proc Natl Acad Sci U S A (2011) 0.95
Protein carbon content evolves in response to carbon availability and may influence the fate of duplicated genes. Proc Biol Sci (2007) 0.95
IL-33 regulates TNF-α dependent effects in synovial fibroblasts. Int J Mol Med (2012) 0.95
Detection of oncofetal h19 RNA in rheumatoid arthritis synovial tissue. Am J Pathol (2003) 0.94
Evolvability and robustness in a complex signalling circuit. Mol Biosyst (2011) 0.94
Genotype networks, innovation, and robustness in sulfur metabolism. BMC Syst Biol (2011) 0.94
Proteinase-3 as the major autoantigen of c-ANCA is strongly expressed in lung tissue of patients with Wegener's granulomatosis. Arthritis Res (2002) 0.93
Multifunctionality and robustness trade-offs in model genetic circuits. Biophys J (2008) 0.93